Hope, hurdles, and hazards
The role of statins in MASLD
a privilege to write this editorial with @NKimer
https://www.sciencedirect.com/science/article/pii/S0973688325000040?dgcid=author
On the terrific original article by @Dr_KMCoop @DeepikaDevuniMD
https://www.sciencedirect.com/science/article/abs/pii/S0973688324010946
The role of statins in MASLD
a privilege to write this editorial with @NKimer
https://www.sciencedirect.com/science/article/pii/S0973688325000040?dgcid=author
On the terrific original article by @Dr_KMCoop @DeepikaDevuniMD
https://www.sciencedirect.com/science/article/abs/pii/S0973688324010946
Comments
What do you think of the possibility of Bempedoic acid for MASLD as well? It acts higher up in the cholesterol pathway and may have some indirect effects on reducing insulin resistance. I know it's $$$ right now, but it could have potential as well.
Mostly just curious! I think any of the GCGR agonists are gonna be game changers liver disease. We'll have Ph2 MASH data from Lilly on Mazdutide summer or early fall. It's a dual GLP-1 Glucagon agonist.